Orlandini G E, Ruggiero L, Gulisano M, Ruggiero M, Villari N, Casamassima F
Department of Human Anatomy and Histology, University of Sassari, Italy.
Arch Ital Anat Embriol. 1991 Apr-Jun;96(2):93-100.
Magnetic Resonance (MR) imaging was used to examine the hematopoietic bone marrow in the vertebral bodies of eight healthy subjects, and of 35 cancer patients who had been previously treated with radiation therapy. MR was instrumental in distinguishing viable hematopoietic tissue (red marrow) from adipose tissue (yellow marrow), whose presence reflected the extent of radiation-induced bone marrow injury. Different water content in proliferating hematopoietic tissue and adipose tissue enabled clear distinction of the two components even inside the same vertebral body. Three patterns of bone marrow viability were observed in irradiated patients: 1. Patients undergoing therapy at the time of MR study, and patients who had received low-intermediate dose several years before MR examination showed no alteration as compared with healthy controls (i.e. homogeneous presence of red marrow). 2. Patients who had received low-intermediate dose few years before MR, showed either partial re-colonization of yellow marrow or almost complete ablation of active red marrow with rare areas of re-colonization. 3. Patients who had received high dose, showed complete depletion of red marrow (fatty substitution) independently of the length of time elapsed since radiation therapy. Therefore, bone marrow recovery after radiation therapy was associate with two variables: received dose and length of time allowed for re-colonization by surviving hematopoietic tissue. In conclusion, our results provide evidence that MR can be purposively used to study composition and distribution of normal bone marrow, and to asses the extent of radiation-induced bone marrow injury; to monitor bone marrow recovery (or the lack of it); and in the general follow-up of treated cancer patients.
利用磁共振(MR)成像检查了8名健康受试者以及35名曾接受过放射治疗的癌症患者椎体中的造血骨髓。MR有助于区分存活的造血组织(红骨髓)和脂肪组织(黄骨髓),黄骨髓的存在反映了放射诱导的骨髓损伤程度。增殖的造血组织和脂肪组织中不同的含水量使得即使在同一椎体内也能清晰区分这两种成分。在接受过放疗的患者中观察到三种骨髓存活模式:1. 在进行MR研究时正在接受治疗的患者,以及在MR检查前数年接受过低-中等剂量放疗的患者,与健康对照组相比无变化(即红骨髓均匀存在)。2. 在MR检查前数年接受过低-中等剂量放疗的患者,要么黄骨髓部分重新定植,要么活跃的红骨髓几乎完全消失,仅有罕见的重新定植区域。3. 接受高剂量放疗的患者,无论放疗后经过的时间长短,均表现为红骨髓完全耗竭(脂肪替代)。因此,放疗后骨髓恢复与两个变量相关:接受的剂量以及存活造血组织重新定植所需的时间。总之,我们的结果表明,MR可用于有目的地研究正常骨髓的组成和分布,评估放射诱导的骨髓损伤程度;监测骨髓恢复情况(或未恢复情况);以及在接受治疗的癌症患者的总体随访中发挥作用。